adenosine has been researched along with benzoxazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baghdoyan, HA; Lydic, R; Watson, CJ; Watson, SL | 1 |
| Li, J; Li, Z; Liu, F; Wang, X; Zhang, Z; Zhuang, X | 1 |
2 other study(ies) available for adenosine and benzoxazoles
| Article | Year |
|---|---|
Thermal nociception is decreased by hypocretin-1 and an adenosine A1 receptor agonist microinjected into the pontine reticular formation of Sprague Dawley rat.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Aging; Animals; Benzoxazoles; Hot Temperature; Intracellular Signaling Peptides and Proteins; Male; Microinjections; Naphthyridines; Neuropeptides; Orexin Receptors; Orexins; Pain; Pain Measurement; Pons; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Reticular Formation; Time Factors; Urea | 2010 |
P-Glycoprotein (ABCB1) limits the brain distribution of YQA-14, a novel dopamine D3 receptor antagonist.
Topics: Acridines; Adenosine; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzoxazoles; Blood-Brain Barrier; Brain; Caco-2 Cells; Dibenzocycloheptenes; Diketopiperazines; Dopamine Antagonists; Half-Life; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Permeability; Piperazines; Quinolines; ROC Curve; Temperature; Tetrahydroisoquinolines | 2015 |